Vice President, Head of Investor Relations
Jan joined as Vice President, Head of Investor Relations in February 2024 and brings more than 25 years of experience spanning the life sciences sector in investor relations (IR), investment research and capital markets. He’s led IR for organizations encompassing the full spectrum of life sciences, including private and public companies, from pre-clinical stage to global commercial enterprises – biopharma, platform technologies, tools, diagnostics and medtech.
Jan joins InflaRx from Olink Proteomics where he was VP, Investor Relations & Capital Markets. His previous IR roles include those at companies focused on oncology and I-O, hematology/oncology, specialty therapeutics and medical technology. Jan’s sell-side experience included roles within boutique and specialty research firms, and equity research positions at several global investment banks. On the buy-side, Jan focused on healthcare and biotech.
Jan holds a Bachelor of Science in Biomedical Engineering from the Tulane University School of Engineering in New Orleans, Louisiana. He is also a CFA charterholder.
